Showing results (1371-1380 of 1,395) with videos related to

Sort By:
Pageof 140
Medrxiv : the Preprint Server for Health Sciences|January 8, 2026
Age- and Sex-Adjusted Myocardial Flow Reserve Percentiles for Personalized Cardiovascular Risk AssessmentLee Joseph, Ludovic Trinquart, Diana M Lopez, et al.
Medrxiv : the Preprint Server for Health Sciences|June 30, 2025
AI-based Hepatic Steatosis Detection and Integrated Hepatic Assessment from Cardiac CT Attenuation Scans Enhances All-cause Mortality Risk Stratification: A Multi-center StudyJirong Yi, Krishna K Patel, Robert J H Miller, et al.
Circulation|June 4, 2026
Incremental Prognostic Value of Subendocardial Myocardial Flow Reserve in Patients With Normal PerfusionDiana M Lopez, Jenifer M Brown, Sanjay Divakaran, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 5, 2025
Long-COVID incidence proportion in adults and children between 2020 and 2024Hannah Mandel, Yun J Yoo, Andrea J Allen, et al.
Space Science Reviews|February 23, 2022
The Emirates Mars MissionH E S Amiri, D Brain, O Sharaf, et al.
Microbiology Resource Announcements|April 7, 2022
Genome Sequences of 22 T1-like Bacteriophages That Infect <i>Enterobacteriales</i>Alyssa Cranston, Parker Danielson, Daniel K Arens, et al.
Science (New York, N.Y.)|March 12, 2016
Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart diseasePaolo Zanoni, Sumeet A Khetarpal, Daniel B Larach, et al.
Geochemistry, Geophysics, Geosystems : G(3)|July 5, 2021
InterCarb: A Community Effort to Improve Interlaboratory Standardization of the Carbonate Clumped Isotope Thermometer Using Carbonate StandardsS M Bernasconi, M Daëron, K D Bergmann, et al.
JAMA|July 17, 2012
Lipid-related markers and cardiovascular disease prediction, Emanuele Di Angelantonio, Pei Gao, et al.
Cardiovascular Diabetology|June 6, 2019
The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) FoundationJean-Charles Fruchart, Raul D Santos, Carlos Aguilar-Salinas, et al.
Pageof 140